Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000844625 | SCV000065130 | pathogenic | Rare genetic deafness | 2011-11-08 | criteria provided, single submitter | clinical testing | The Val101fs variant in CLRN1 has been identified in the homozygous state in two Lebanese siblings with Usher syndrome (Akoury 2011). This variant results in a frameshift at position 101 leading to a premature stop 27 codons downstream, whi ch is predicted to lead to a truncated or absent protein. In summary, this varia nt meets our criteria to be classified as pathogenic. |
Counsyl | RCV000041435 | SCV000220930 | likely pathogenic | Usher syndrome type 3 | 2014-12-02 | criteria provided, single submitter | literature only | |
Labcorp Genetics |
RCV002513586 | SCV003525371 | pathogenic | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val101Serfs*27) in the CLRN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLRN1 are known to be pathogenic (PMID: 11524702, 24498627). This variant is present in population databases (rs397517932, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 21675857). ClinVar contains an entry for this variant (Variation ID: 48145). For these reasons, this variant has been classified as Pathogenic. |
Faculty of Health Sciences, |
RCV002273943 | SCV002097251 | pathogenic | Usher syndrome | 2022-02-12 | no assertion criteria provided | research |